Shoaeb Mohammad Syed
Shoaeb Mohammad Syed has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Kranti Satpute
Department of Quality Assurance, Dayanand Education Society’s Dayanand College of Pharmacy, Latur, Maharashtra 413531, India
4 shared publicationsAbdulkarim S. Binshaya
Department of Medical Laboratory, College of Applied Medical Sciences Prince Sattam bin Abdulaziz University Al‐Kharj Saudi Arabia
1 shared publicationAbhishek Nidbane
1 shared publicationAdil Abalkhail
Department of Public Health, College of Applied Medical Sciences Qassim University Buraydah Saudi Arabia
1 shared publicationAishwarya Dound
1 shared publicationAjinkya Holkar
Department of Pharmacy, Dr. Vedprakash Patil Pharmacy College, Aurangabad MS, India
1 shared publication
Latest Publications
- Open Access
- 15 May 2026
- Published by Elsevier in Medicine in Novel Technology and Devices
- Vol. 31
Transferosomes in transdermal therapy: Opportunities, challenges, and innovations
- 15 May 2026
- Published by Elsevier in Medicine in Novel Technology and Devices
- Vol. 31
Open AccessTransferosomes in transdermal therapy: Opportunities, challenges, and innovations
- 10 May 2026
- Published by Elsevier in Current Research in Translational Medicine
- Vol. 74 (3) , 103589
Nanogels as innovative drug carriers for RNA-based skin cancer therapy: mechanistic insights and RNA encapsulation
- 10 May 2026
- Published by Elsevier in Current Research in Translational Medicine
- Vol. 74 (3) , 103589
Nanogels as innovative drug carriers for RNA-based skin cancer therapy: mechanistic insights and RNA encapsulation
- Open Access
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Journal of Bio-X Research
- Vol. 9
Three-Dimensional Printing of Smart Biomaterials: Emerging Strategies for Cancer Therapy and Neurological Repair
The convergence of 3-dimensional (3D) printing and smart biomaterials represents a transformative approach in biomedical engineering, particularly for oncology and neurology. Smart biomaterials, including stimuli-responsive polymers, nanocomposites, and hydrogels, offer unique advantages, such as high biocompatibility, tunable mechanical properties, and dynamic responsiveness to biological stimuli. These characteristics enable the fabrication of patient-specific constructs that facilitate therapeutic actions via stimuli-responsive behaviors. In oncology, 3D-bioprinted models, such as tumor organoids and cancer progression platforms, provide biologically relevant environments for investigating tumor biology, drug resistance, and personalized treatment responses, thereby accelerating the development of precision medicine. In neurological applications, 3D-printed neural scaffolds and implants exhibit significant promise for repairing central nervous system injuries by promoting neural cell growth and supporting axonal regeneration. Furthermore, hydrogel-based 3D constructs integrated with controlled drug delivery systems facilitate localized, sustained, and targeted therapeutic delivery, minimizing systemic side effects. Despite this promising potential, challenges remain, including a limited library of printable biomaterials, scalability, and regulatory issues. In this review, recent advancements in the 3D printing of smart biomaterials are summarized, their applications in cancer and neurological therapies are critically analyzed, and limitations and future directions for clinical translation are discussed.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Journal of Bio-X Research
- Vol. 9
Open AccessThree-Dimensional Printing of Smart Biomaterials: Emerging Strategies for Cancer Therapy and Neurological Repair
The convergence of 3-dimensional (3D) printing and smart biomaterials represents a transformative approach in biomedical engineering, particularly for oncology and neurology. Smart biomaterials, including stimuli-responsive polymers, nanocomposites, and hydrogels, offer unique advantages, such as high biocompatibility, tunable mechanical properties, and dynamic responsiveness to biological stimuli. These characteristics enable the fabrication of patient-specific constructs that facilitate therapeutic actions via stimuli-responsive behaviors. In oncology, 3D-bioprinted models, such as tumor organoids and cancer progression platforms, provide biologically relevant environments for investigating tumor biology, drug resistance, and personalized treatment responses, thereby accelerating the development of precision medicine. In neurological applications, 3D-printed neural scaffolds and implants exhibit significant promise for repairing central nervous system injuries by promoting neural cell growth and supporting axonal regeneration. Furthermore, hydrogel-based 3D constructs integrated with controlled drug delivery systems facilitate localized, sustained, and targeted therapeutic delivery, minimizing systemic side effects. Despite this promising potential, challenges remain, including a limited library of printable biomaterials, scalability, and regulatory issues. In this review, recent advancements in the 3D printing of smart biomaterials are summarized, their applications in cancer and neurological therapies are critically analyzed, and limitations and future directions for clinical translation are discussed.
- 27 May 2025
- Published by Wiley in Drug Development Research
- Vol. 86 (4) , e70106
Topical Miconazole Nanogel: In Vitro Characterization, In Vivo Skin Irritation, and Enhanced Antifungal Efficacy
This study focused on the development of a miconazole nanogel formulation. The nanogel was prepared using the solvent diffusion method (high‐speed homogenization) with Carbopol 940/chitosan/locust bean gum (Different gelling agents were used) and triethanolamine. The formulation was thoroughly evaluated for various physicochemical properties, including appearance, pH, FTIR analysis, viscosity, washability, spreadability, extrudability, drug content, entrapment efficiency, particle size, zeta potential, optical microscopy, differential scanning calorimetry (DSC), skin irritation, ex‐vivo skin penetration, in‐vitro diffusion, in‐vitro antifungal activity, and stability. The prepared nanogel exhibited a clear, homogenous, white appearance with a pH compatible to skin pH (5.4−6.2). FTIR analysis confirmed the compatibility between the drug and polymers. The nanogel demonstrated good viscosity (3239−4175 cps), washability, and spreadability (2.5−3.5). Extrudability studies revealed easy extrusion of the formulation. Drug content ranged from 90.15% to 99.36%, with entrapment efficiency between 78.85% and 95.00%. The nanogel had a particle size of 534 nm and a zeta potential of −37.7 mV. Microscopic analysis showed spherical nanoparticles. DSC analysis indicated no change in the melting point of miconazole, which is one of the characteristics that confirm the stability of the drug with excipients. Skin irritation studies on rats revealed no erythema or edema after 24 h. In‐vitro drug release ranged from 86.12% to 99.00%. Ex‐vivo skin penetration and retention were higher for the nanogel than the marketed gel. In‐vitro antifungal studies demonstrated superior activity of the nanogel compared to the marketed and standard formulations. Stability studies revealed no significant changes in drug content, extrudability, spreadability, pH, or in‐vitro drug release. The developed miconazole nanogel formulation exhibited promising characteristics, including controlled drug release, enhanced skin penetration, and antifungal activity. It represents a potential advancement in topical antifungal therapy.
- 27 May 2025
- Published by Wiley in Drug Development Research
- Vol. 86 (4) , e70106
Topical Miconazole Nanogel: In Vitro Characterization, In Vivo Skin Irritation, and Enhanced Antifungal Efficacy
This study focused on the development of a miconazole nanogel formulation. The nanogel was prepared using the solvent diffusion method (high‐speed homogenization) with Carbopol 940/chitosan/locust bean gum (Different gelling agents were used) and triethanolamine. The formulation was thoroughly evaluated for various physicochemical properties, including appearance, pH, FTIR analysis, viscosity, washability, spreadability, extrudability, drug content, entrapment efficiency, particle size, zeta potential, optical microscopy, differential scanning calorimetry (DSC), skin irritation, ex‐vivo skin penetration, in‐vitro diffusion, in‐vitro antifungal activity, and stability. The prepared nanogel exhibited a clear, homogenous, white appearance with a pH compatible to skin pH (5.4−6.2). FTIR analysis confirmed the compatibility between the drug and polymers. The nanogel demonstrated good viscosity (3239−4175 cps), washability, and spreadability (2.5−3.5). Extrudability studies revealed easy extrusion of the formulation. Drug content ranged from 90.15% to 99.36%, with entrapment efficiency between 78.85% and 95.00%. The nanogel had a particle size of 534 nm and a zeta potential of −37.7 mV. Microscopic analysis showed spherical nanoparticles. DSC analysis indicated no change in the melting point of miconazole, which is one of the characteristics that confirm the stability of the drug with excipients. Skin irritation studies on rats revealed no erythema or edema after 24 h. In‐vitro drug release ranged from 86.12% to 99.00%. Ex‐vivo skin penetration and retention were higher for the nanogel than the marketed gel. In‐vitro antifungal studies demonstrated superior activity of the nanogel compared to the marketed and standard formulations. Stability studies revealed no significant changes in drug content, extrudability, spreadability, pH, or in‐vitro drug release. The developed miconazole nanogel formulation exhibited promising characteristics, including controlled drug release, enhanced skin penetration, and antifungal activity. It represents a potential advancement in topical antifungal therapy.
- Open Access
- 1 March 2025
- Published by KEAI Publishing in Journal of Holistic Integrative Pharmacy
- Vol. 6 (1) , 57-63
Formulation and evaluation of carbamazepine loaded ethosomal nasal in-situ gel for brain targeted drug delivery
- 1 March 2025
- Published by KEAI Publishing in Journal of Holistic Integrative Pharmacy
- Vol. 6 (1) , 57-63
Open AccessFormulation and evaluation of carbamazepine loaded ethosomal nasal in-situ gel for brain targeted drug delivery
- Open Access
- 1 March 2025
- Published by KEAI Publishing in Journal of Dermatologic Science and Cosmetic Technology
- Vol. 2 (1)
Development of a novel luliconazole transferosomal gel for enhanced antifungal delivery
- 1 March 2025
- Published by KEAI Publishing in Journal of Dermatologic Science and Cosmetic Technology
- Vol. 2 (1)
Open AccessDevelopment of a novel luliconazole transferosomal gel for enhanced antifungal delivery
- Open Access
- 19 March 2024
- Published by Bentham Science Publishers Ltd. in Current Indian Science
- Vol. 02, 1-6
Materiovigilance as a Health Care Safety in India: A Regulatory Prospective
Over the past few centuries, life-saving tools have been extensively used across the globe. The use of medical devices has increased adverse events associated with them. Materiovigilance is the process of identifying, collecting, reporting, and examining unfavorable events connected to medical devices in order to prevent the recurrence of such occurrences. Several countries keep an eye on medical products once they are commercialized. Other nations with similar programs include France, Australia, and the United Kingdom, in addition to the Medical Device Reporting (MDR) programme in the United States. This article addressed how some types of medical equipment might be dangerous and how a Materiovigilance programme is essential. : This page provides information about how to report adverse reactions to these medical devices, as well as what they are. : In many countries, post-marketing surveillance for medications has been initiated but is not as reliable and advanced as it is today. By monitoring adverse events related to medical devices, generating safety data, educating stakeholders, and recommending appropriate procedures and interventions, the Indian Pharmacopeia Commission established the committee on July 6, 2015. : Monitoring adverse events related to medical device usage can increase patient safety. On the basis of safety data gathered and generated, the Central Drugs Standard Control Organization (CDSCO) will make recommendations about the safe use of medical devices in the Indian population.
- 19 March 2024
- Published by Bentham Science Publishers Ltd. in Current Indian Science
- Vol. 02, 1-6
Open AccessMateriovigilance as a Health Care Safety in India: A Regulatory Prospective
Over the past few centuries, life-saving tools have been extensively used across the globe. The use of medical devices has increased adverse events associated with them. Materiovigilance is the process of identifying, collecting, reporting, and examining unfavorable events connected to medical devices in order to prevent the recurrence of such occurrences. Several countries keep an eye on medical products once they are commercialized. Other nations with similar programs include France, Australia, and the United Kingdom, in addition to the Medical Device Reporting (MDR) programme in the United States. This article addressed how some types of medical equipment might be dangerous and how a Materiovigilance programme is essential. : This page provides information about how to report adverse reactions to these medical devices, as well as what they are. : In many countries, post-marketing surveillance for medications has been initiated but is not as reliable and advanced as it is today. By monitoring adverse events related to medical devices, generating safety data, educating stakeholders, and recommending appropriate procedures and interventions, the Indian Pharmacopeia Commission established the committee on July 6, 2015. : Monitoring adverse events related to medical device usage can increase patient safety. On the basis of safety data gathered and generated, the Central Drugs Standard Control Organization (CDSCO) will make recommendations about the safe use of medical devices in the Indian population.
- 15 June 2023
- Published by Bentham Science Publishers Ltd. in Current Cosmetic Science
- Vol. 2, 1
Formulation and Evaluation of Herbal Hair Dye: A Laboratory Scale Project
Aim: This research was conducted to make the option for chemical-based semisynthetic and synthetic hair dyes to overcome the problems with the use of synthetic dyes and the acceptance rate by the public. The work involves the use of some novel natural ingredients with novel combinations. Methods: The herbal hair dye was prepared y using various natural agents reported to possess the desired properties. The plants were collected from the herbal garden of Dr. VedprakashPatil Pharmacy College, Aurangabad & authenticated by the Dept. of Pharmacognosy. All ingredients were passed through sieves and mixed thoroughly to get a homogenous mixture; the mixture was dissolved in water and applied to the hairs for the evaluation of various parameters such as organoleptic physicochemical, patch test & stability. Results: This Herbal hair dye prepared in the laboratory is made with all good quality materials. It was tested in the laboratory and was found to be very safe for the regular use of this herbal hair dye after several time intervals of time. All evaluation parameters were found to be within the limits as prescribed for the safe use of hair dye. Conclusion: The prepared herbal hair dye neither shows any side effects nor skin infections. It nourishes the skin on the scalp and hair. This herbal hair dye also aids in dandruff treatment by removing excess oil from the scalp. If such herbal dye is used frequently or regularly, it will give a manageable, fizz-free colored hair benefiting human as well as the industry. The formulation is natural in origin with effective benefits compared to the marketed formulation and cost-effective. : As the process is simple, small scale cosmetic industry can make use of the technique.
- 15 June 2023
- Published by Bentham Science Publishers Ltd. in Current Cosmetic Science
- Vol. 2, 1
Formulation and Evaluation of Herbal Hair Dye: A Laboratory Scale Project
Aim: This research was conducted to make the option for chemical-based semisynthetic and synthetic hair dyes to overcome the problems with the use of synthetic dyes and the acceptance rate by the public. The work involves the use of some novel natural ingredients with novel combinations. Methods: The herbal hair dye was prepared y using various natural agents reported to possess the desired properties. The plants were collected from the herbal garden of Dr. VedprakashPatil Pharmacy College, Aurangabad & authenticated by the Dept. of Pharmacognosy. All ingredients were passed through sieves and mixed thoroughly to get a homogenous mixture; the mixture was dissolved in water and applied to the hairs for the evaluation of various parameters such as organoleptic physicochemical, patch test & stability. Results: This Herbal hair dye prepared in the laboratory is made with all good quality materials. It was tested in the laboratory and was found to be very safe for the regular use of this herbal hair dye after several time intervals of time. All evaluation parameters were found to be within the limits as prescribed for the safe use of hair dye. Conclusion: The prepared herbal hair dye neither shows any side effects nor skin infections. It nourishes the skin on the scalp and hair. This herbal hair dye also aids in dandruff treatment by removing excess oil from the scalp. If such herbal dye is used frequently or regularly, it will give a manageable, fizz-free colored hair benefiting human as well as the industry. The formulation is natural in origin with effective benefits compared to the marketed formulation and cost-effective. : As the process is simple, small scale cosmetic industry can make use of the technique.
- 13 May 2016
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 20 (3) , 325
CONTROLLED POROSITY OSMOTIC TABLET OF ATENOLOL: IN-VITRO AND IN-VIVO EVALUATION
CONTROLLED POROSITY OSMOTIC TABLET OF ATENOLOL: IN-VITRO AND IN-VIVO EVALUATION
- 13 May 2016
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 20 (3) , 325
CONTROLLED POROSITY OSMOTIC TABLET OF ATENOLOL: IN-VITRO AND IN-VIVO EVALUATION
CONTROLLED POROSITY OSMOTIC TABLET OF ATENOLOL: IN-VITRO AND IN-VIVO EVALUATION